BDTX · ISSUER CIK 1701541
Black Diamond Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Black Diamond Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 21, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 202617:45 | Sep 18, 2026 | BDTX | Director | A · Grant | $1.93 | +7,707 | 110,236 | +8% | $15K | ||
| Sep 21, 202617:30 | Sep 18, 2026 | BDTX | Director | A · Grant | $1.93 | +6,801 | 51,840 | +15% | $13K |